cardio-met (@cardiomet_ce) 's Twitter Profile
cardio-met

@cardiomet_ce

Your only source for JOINT-ACCREDITED SoMe-delivered, serialized professional cardiometabolic education. Physicians, nurses, pharmacists--come one, come all!

ID: 1327271529181274114

linkhttp://www.cardiometabolic-ce.com calendar_today13-11-2020 15:26:28

10,10K Tweet

4,4K Followers

81 Following

cardio-met (@cardiomet_ce) 's Twitter Profile Photo

19a) A final analysis from #ATTRibute_CM, led by Kevin Alexander, evaluated the stability & improvement in #NYHA class on acoramidis vs placebo. At 30mo, 35.9% of pts in the #acoramidis group and 53.0% of pts in the placebo group had worsened in NYHA Class or had missing values.

19a) A final analysis from #ATTRibute_CM, led by <a href="/KMAlexanderMD/">Kevin Alexander</a>, evaluated the stability &amp; improvement in #NYHA class on acoramidis vs placebo. At 30mo, 35.9% of pts in the #acoramidis group and 53.0% of pts in the placebo group had worsened in NYHA Class or had missing values.